Oral antihistamines for allergic disorders

Drug and Therapeutics Bulletin

Volumn 40, Issue 8, 2002, Pages 59-62

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ALIMEMAZINE; ALLERGEN; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZATADINE; BROMPHENIRAMINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; CYPROHEPTADINE; DESLORATADINE; DRUG METABOLITE; ERYTHROMYCIN; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; KETOCONAZOLE; KETOTIFEN; LEVOCETIRIZINE; LORATADINE; MIZOLASTINE; NEFAZODONE; NON PRESCRIPTION DRUG; PROMETHAZINE; PROSTAGLANDIN DERIVATIVE; TERFENADINE;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; BLOOD BRAIN BARRIER; CHILD; CLINICAL TRIAL; DROWSINESS; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG INDICATION; DRUG USE; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HAY FEVER; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREGNANCY; PRURITUS; UNITED KINGDOM; URINE RETENTION; URTICARIA; XEROSTOMIA;

EID: 0036679341     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2002.40859     Document Type: Article

References (41)

1. Desloratadine: A new, nonsedating, oral antihistamine
2. Activastine in seasonal allergic rhinitis: Two randomized crossover studies to evaluate efficacy and safety
3. Brompheniramine, terfenadine, and placebo in allergic rhinitis
4. Brompheniramine maleate: A double-blind placebo-controlled comparison with terfenadine for symptoms of allergic rhinitis
5. Multicenter, double-blind, multiple-dose, parallel-groups efficacy and safety trial of azelastine, chlorpheniramine, and placebo in the treatment of spring allergic rhinitis
6. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis
7. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis
8. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
9. 1-receptor antagonist, in patients with seasonal allergic rhinitis: Assessment during the spring and fall allergy seasons
10. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180mg once daily) and cetirizine in seasonal allergic rhinitis
11. Once-daily fexofenadine HCI improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
12. Efficacy and safety of levocetirizine in seasonal allergic rhinitis
13. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis
14. Efficacy and safety of mizolastine in seasonal allergic rhinitis
15. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis
16. Allergic rhinitis and its impact on asthma (ARIA) in collaboration with the World Health Organization (WHO)
17. Continuous versus on demand treatment with cetirizine for allergic rhinitis
18. Efficacy and safety of loratadine (10mg once daily), terfenadine (60mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
19. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis
20. Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
21. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120mg, loratadine 10mg and placebo administered once daily for the treatment of seasonal allergic rhinitis
22. A placebo-controlled trial of cetirizine in seasonal allergic rhinoconjunctivitis in children aged 6 to 12 years
23. Cetirizine for seasonal allergic rhinitis in children aged 2-6 years: A double-blind comparison with placebo
24. Activastine versus clemastine in the treatment of chronic idiopathic urticaria: A double blind placebo-controlled study
25. Urticaria: Clinical efficacy of cetrizine in comparison with hydroxyzine and placebo
26. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study
27. Fexofenadine HCI is safe and effective for treatment of chronic idiopathic urticaria
28. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria
29. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria
30. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria
31. Effect of 60mg twice-daily fexofenadine HCI on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria
32. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis
33. Sedative effects of antihistamines: Safety, performance, learning, and quality of life
34. The effects of antihistamines on cognition and performance
35. Seasonal allergic rhinitis and antihistamine effects on children's learning
36. Sedation and antihistamines: A review of inter-drug differences using proportional impairment ratios
37. 1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects
38. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation
39. Cardiac ion channels and antihistamines: Possible mechanisms of cardiotoxicity
40. The use of newer asthma and allergy medications during pregnancy
41. Second-generation antihistamines: A comparative review